{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:46:18Z","timestamp":1784259978174,"version":"3.55.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006244","name":"Kika","doi-asserted-by":"crossref","award":["363"],"award-info":[{"award-number":["363"]}],"id":[{"id":"10.13039\/501100006244","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alexandre Suerman Stipend"},{"DOI":"10.13039\/100017790","name":"European Proteomics Infrastructure Consortium providing access","doi-asserted-by":"publisher","award":["823839"],"award-info":[{"award-number":["823839"]}],"id":[{"id":"10.13039\/100017790","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NWO funded National Road Map for Large-scale Infrastructures program X-Omics","award":["184.034.019"],"award-info":[{"award-number":["184.034.019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for leukemia and a range of non-malignant disorders. The success of the therapy is hampered by occurrence of acute graft-versus-host disease (aGvHD); an inflammatory response damaging recipient organs, with gut, liver, and skin being the most susceptible. Intestinal GvHD injury is often a life-threatening complication in patients unresponsive to steroid treatment. Allogeneic mesenchymal stromal\/stem cell (MSC) infusions are a promising potential treatment for steroid-resistant aGvHD. Data from our institution and others demonstrate rescue of approximately 40\u201350% of aGvHD patients with MSCs in Phase I, II studies and minor side effects. Although promising, better understanding of MSC mode of action and patient response to MSC-based therapy is essential to improve this lifesaving treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Single cell human small intestine organoids were embedded in Matrigel, grown for 5 days and treated with busulfan for 48 h. Organoids damaged by treatment with busulfan or control organoids were co-cultured with 5000, 10,000, and 50,000 MSCs for 24 h, 48 h or 7 days and the analyses such as surface area determination, proliferation and apoptosis assessment, RNA sequencing and proteomics were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here, we developed a 3D co-culture model of human small intestinal organoids and MSCs, which allows to study the regenerative effects of MSCs on intestinal epithelium in a more physiologically relevant setting than existing in vitro systems. Using this model we mimicked chemotherapy-mediated damage of the intestinal epithelium. The treatment with busulfan, the chemotherapeutic commonly used as conditioning regiment before the HSCT, affected pathways regulating epithelial to mesenchymal transition, proliferation, and apoptosis in small intestinal organoids, as shown by transcriptomic and proteomic analysis. The co-culture of busulfan-treated intestinal organoids with MSCs reversed the effects of busulfan on the transcriptome and proteome of intestinal epithelium, which we also confirmed by functional evaluation of proliferation and apoptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, we demonstrate that our in vitro co-culture system is a new valuable tool to facilitate the investigation of the molecular mechanisms behind the therapeutic effects of MSCs on damaged intestinal epithelium. This could benefit further optimization of the use of MSCs in HSCT patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-024-03738-9","type":"journal-article","created":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T20:01:48Z","timestamp":1714334508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mesenchymal stromal\/stem cells promote intestinal epithelium regeneration after chemotherapy-induced damage"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6986-0004","authenticated-orcid":false,"given":"B.","family":"Yetkin-Arik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1225-9963","authenticated-orcid":false,"given":"S. A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7879-4291","authenticated-orcid":false,"given":"S.","family":"Varderidou-Minasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1043-3638","authenticated-orcid":false,"given":"B.","family":"Westendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-P.","family":"Skarp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5093-5945","authenticated-orcid":false,"given":"M.","family":"Altelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3984-5620","authenticated-orcid":false,"given":"C. A.","family":"Lindemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8420-2029","authenticated-orcid":false,"given":"M. J.","family":"Lorenowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"issue":"17","key":"3738_CR1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354(17):1813\u201326.","journal-title":"N Engl J Med"},{"issue":"1","key":"3738_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","volume":"119","author":"M Jagasia","year":"2012","unstructured":"Jagasia M, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119(1):296\u2013307.","journal-title":"Blood"},{"issue":"4","key":"3738_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.det.2019.05.014","volume":"37","author":"V Ramachandran","year":"2019","unstructured":"Ramachandran V, Kolli SS, Strowd LC. Review of graft-versus-host disease. Dermatol Clin. 2019;37(4):569\u201382.","journal-title":"Dermatol Clin"},{"key":"3738_CR4","doi-asserted-by":"crossref","unstructured":"Jansen SA, et al. Chemotherapy-induced intestinal injury promotes Galectin-9-driven modulation of T cell function. bioRxiv. 2023.","DOI":"10.1101\/2023.04.30.538862"},{"issue":"6","key":"3738_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nri3212","volume":"12","author":"BR Blazar","year":"2012","unstructured":"Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol. 2012;12(6):443\u201358.","journal-title":"Nat Rev Immunol"},{"key":"3738_CR6","doi-asserted-by":"publisher","first-page":"601953","DOI":"10.1155\/2011\/601953","volume":"2011","author":"JR Westin","year":"2011","unstructured":"Westin JR, et al. Steroid-refractory acute GVHD: predictors and outcomes. Adv Hematol. 2011;2011:601953.","journal-title":"Adv Hematol"},{"issue":"11","key":"3738_CR7","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41409-019-0544-y","volume":"54","author":"L Axt","year":"2019","unstructured":"Axt L, et al. Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2019;54(11):1805\u201314.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"3738_CR8","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1182\/blood-2006-08-013995","volume":"109","author":"ML Macmillan","year":"2007","unstructured":"Macmillan ML, et al. A phase 2\/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease. Blood. 2007;109(6):2657\u201362.","journal-title":"Blood"},{"issue":"14","key":"3738_CR9","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s40265-019-01174-1","volume":"79","author":"D Mannina","year":"2019","unstructured":"Mannina D, Kr\u00f6ger N. Janus kinase inhibition for graft-versus-host disease: current status and future prospects. Drugs. 2019;79(14):1499\u2013509.","journal-title":"Drugs"},{"key":"3738_CR10","doi-asserted-by":"publisher","first-page":"761616","DOI":"10.3389\/fimmu.2021.761616","volume":"12","author":"K Kelly","year":"2021","unstructured":"Kelly K, Rasko JEJ. Mesenchymal stromal cells for the treatment of graft versus host disease. Front Immunol. 2021;12:761616.","journal-title":"Front Immunol"},{"issue":"19","key":"3738_CR11","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","volume":"382","author":"R Zeiser","year":"2020","unstructured":"Zeiser R, et al. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease. N Engl J Med. 2020;382(19):1800\u201310.","journal-title":"N Engl J Med"},{"issue":"1","key":"3738_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12015-021-10231-w","volume":"18","author":"U Galderisi","year":"2022","unstructured":"Galderisi U, Peluso G, Di Bernardo G. Clinical trials based on mesenchymal stromal cells are exponentially increasing: where are we in recent years? Stem Cell Rev Rep. 2022;18(1):23\u201336.","journal-title":"Stem Cell Rev Rep"},{"issue":"4","key":"3738_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3904\/kjim.2013.28.4.387","volume":"28","author":"N Kim","year":"2013","unstructured":"Kim N, Cho SG. Clinical applications of mesenchymal stem cells. Korean J Intern Med. 2013;28(4):387\u2013402.","journal-title":"Korean J Intern Med"},{"key":"3738_CR14","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1242\/jcs.02932","volume":"119","author":"L da Silva Meirelles","year":"2006","unstructured":"da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119:2204\u201313.","journal-title":"J Cell Sci"},{"issue":"13","key":"3738_CR15","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.7150\/thno.40122","volume":"10","author":"S Varderidou-Minasian","year":"2020","unstructured":"Varderidou-Minasian S, Lorenowicz MJ. Mesenchymal stromal\/stem cell-derived extracellular vesicles in tissue repair: challenges and opportunities. Theranostics. 2020;10(13):5979\u201397.","journal-title":"Theranostics"},{"issue":"1","key":"3738_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","volume":"7","author":"JL Spees","year":"2016","unstructured":"Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem\/stromal cell function. Stem Cell Res Ther. 2016;7(1):125.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"3738_CR17","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/leu.2015.89","volume":"29","author":"LC Te Boome","year":"2015","unstructured":"Te Boome LC, et al. Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells. Leukemia. 2015;29(9):1839\u201346.","journal-title":"Leukemia"},{"issue":"5","key":"3738_CR18","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","volume":"141","author":"T Sato","year":"2011","unstructured":"Sato T, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium. Gastroenterology. 2011;141(5):1762\u201372.","journal-title":"Gastroenterology"},{"key":"3738_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aay8556","author":"S Takashima","year":"2019","unstructured":"Takashima S, et al. T cell-derived interferon-\u03b3 programs stem cell death in immune-mediated intestinal damage. Sci Immunol. 2019. https:\/\/doi.org\/10.1126\/sciimmunol.aay8556.","journal-title":"Sci Immunol"},{"issue":"4","key":"3738_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"issue":"4","key":"3738_CR21","doi-asserted-by":"publisher","first-page":"906","DOI":"10.7150\/thno.20746","volume":"8","author":"LA Vonk","year":"2018","unstructured":"Vonk LA, et al. Mesenchymal stromal\/stem cell-derived extracellular vesicles promote human cartilage regeneration in vitro. Theranostics. 2018;8(4):906\u201320.","journal-title":"Theranostics"},{"issue":"6","key":"3738_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S1474-4422(22)00117-X","volume":"21","author":"LM Baak","year":"2022","unstructured":"Baak LM, et al. Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study. Lancet Neurol. 2022;21(6):528\u201336.","journal-title":"Lancet Neurol"},{"issue":"12","key":"3738_CR23","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1089\/ten.tea.2008.0666","volume":"15","author":"HJ Prins","year":"2009","unstructured":"Prins HJ, et al. Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum. Tissue Eng Part A. 2009;15(12):3741\u201351.","journal-title":"Tissue Eng Part A"},{"issue":"11","key":"3738_CR24","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1038\/s41409-020-0910-9","volume":"55","author":"LE van der Wagen","year":"2020","unstructured":"van der Wagen LE, et al. Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile. Bone Marrow Transplant. 2020;55(11):2188\u201392.","journal-title":"Bone Marrow Transplant"},{"issue":"7583","key":"3738_CR25","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature16460","volume":"528","author":"CA Lindemans","year":"2015","unstructured":"Lindemans CA, et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature. 2015;528(7583):560\u20134.","journal-title":"Nature"},{"key":"3738_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13059-016-0938-8","volume":"17","author":"T Hashimshony","year":"2016","unstructured":"Hashimshony T, et al. CEL-Seq2: sensitive highly-multiplexed single-cell RNA-Seq. Genome Biol. 2016;17:77.","journal-title":"Genome Biol"},{"issue":"5","key":"3738_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589\u201395.","journal-title":"Bioinformatics"},{"issue":"12","key":"3738_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"3738_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 2013;14:128.","journal-title":"BMC Bioinform"},{"key":"3738_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1742-4690-3-2","volume":"3","author":"JM Ruijter","year":"2006","unstructured":"Ruijter JM, et al. Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology. Retrovirology. 2006;3:2.","journal-title":"Retrovirology"},{"issue":"5","key":"3738_CR31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1349-7006.2004.tb03231.x","volume":"95","author":"T Iwamoto","year":"2004","unstructured":"Iwamoto T, et al. DNA intrastrand cross-link at the 5\u2032-GA-3\u2032 sequence formed by busulfan and its role in the cytotoxic effect. Cancer Sci. 2004;95(5):454\u20138.","journal-title":"Cancer Sci"},{"issue":"13","key":"3738_CR32","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s00018-019-03085-6","volume":"76","author":"H Kaur","year":"2019","unstructured":"Kaur H, Moreau R. Role of mTORC1 in intestinal epithelial repair and tumorigenesis. Cell Mol Life Sci. 2019;76(13):2525\u201346.","journal-title":"Cell Mol Life Sci"},{"key":"3738_CR33","doi-asserted-by":"publisher","first-page":"153303382098010","DOI":"10.1177\/1533033820980104","volume":"19","author":"P Wang","year":"2020","unstructured":"Wang P, Li X, Xie Y. B4GalT1 regulates apoptosis and autophagy of glioblastoma in vitro and in vivo. Technol Cancer Res Treat. 2020;19:1533033820980104.","journal-title":"Technol Cancer Res Treat"},{"issue":"9","key":"3738_CR34","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s13238-011-1092-4","volume":"2","author":"K Ito","year":"2011","unstructured":"Ito K, et al. The role of the CNOT1 subunit of the CCR4-NOT complex in mRNA deadenylation and cell viability. Protein Cell. 2011;2(9):755\u201363.","journal-title":"Protein Cell"},{"issue":"1","key":"3738_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/JME-11-0132","volume":"48","author":"X Lu","year":"2012","unstructured":"Lu X, et al. The membrane topological analysis of 3\u03b2-hydroxysteroid-Delta24 reductase (DHCR24) on endoplasmic reticulum. J Mol Endocrinol. 2012;48(1):1\u20139.","journal-title":"J Mol Endocrinol"},{"issue":"45","key":"3738_CR36","doi-asserted-by":"publisher","first-page":"72795","DOI":"10.18632\/oncotarget.11973","volume":"7","author":"L Lu","year":"2016","unstructured":"Lu L, et al. DRG1 is a potential oncogene in lung adenocarcinoma and promotes tumor progression via spindle checkpoint signaling regulation. Oncotarget. 2016;7(45):72795\u2013806.","journal-title":"Oncotarget"},{"key":"3738_CR37","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201798359","author":"TP Miettinen","year":"2018","unstructured":"Miettinen TP, et al. Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4\/6 inhibitor palbociclib. Embo J. 2018. https:\/\/doi.org\/10.15252\/embj.201798359.","journal-title":"Embo J"},{"key":"3738_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.gene.2018.06.034","volume":"673","author":"Y Yin","year":"2018","unstructured":"Yin Y, et al. The function and clinical significance of eIF3 in cancer. Gene. 2018;673:130\u20133.","journal-title":"Gene"},{"issue":"4","key":"3738_CR39","doi-asserted-by":"publisher","first-page":"9780","DOI":"10.1080\/21655979.2022.2060777","volume":"13","author":"H Ren","year":"2022","unstructured":"Ren H, et al. Matrine impedes colorectal cancer proliferation and migration by downregulating endoplasmic reticulum lipid raft associated protein 1 expression. Bioengineered. 2022;13(4):9780\u201391.","journal-title":"Bioengineered"},{"issue":"9","key":"3738_CR40","doi-asserted-by":"publisher","first-page":"e23425","DOI":"10.1002\/jcla.23425","volume":"34","author":"J Zhu","year":"2020","unstructured":"Zhu J, et al. HIP1R acts as a tumor suppressor in gastric cancer by promoting cancer cell apoptosis and inhibiting migration and invasion through modulating Akt. J Clin Lab Anal. 2020;34(9):e23425.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"3738_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12935-021-01997-7","volume":"21","author":"Y Hu","year":"2021","unstructured":"Hu Y, et al. IFI35 is involved in the regulation of the radiosensitivity of colorectal cancer cells. Cancer Cell Int. 2021;21(1):290.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"3738_CR42","first-page":"908","volume":"43","author":"Y Chen","year":"2020","unstructured":"Chen Y, et al. Interleukin 1\u03b2\/1RA axis in colorectal cancer regulates tumor invasion, proliferation and apoptosis via autophagy. Oncol Rep. 2020;43(3):908\u201318.","journal-title":"Oncol Rep"},{"issue":"21","key":"3738_CR43","doi-asserted-by":"publisher","first-page":"8186","DOI":"10.3390\/ijms21218186","volume":"21","author":"H Hahn","year":"2020","unstructured":"Hahn H, et al. Structural insight on functional regulation of human MINERVA protein. Int J Mol Sci. 2020;21(21):8186.","journal-title":"Int J Mol Sci"},{"key":"3738_CR44","doi-asserted-by":"publisher","first-page":"618902","DOI":"10.3389\/fonc.2020.618902","volume":"10","author":"J Qi","year":"2020","unstructured":"Qi J, et al. Comprehensively analyzed macrophage-regulated genes indicate that PSMA2 promotes colorectal cancer progression. Front Oncol. 2020;10:618902.","journal-title":"Front Oncol"},{"issue":"11","key":"3738_CR45","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1136\/gutjnl-2020-321386","volume":"70","author":"S Song","year":"2021","unstructured":"Song S, et al. Reticulon 3-mediated Chk2\/p53 activation suppresses hepatocellular carcinogenesis and is blocked by hepatitis B virus. Gut. 2021;70(11):2159\u201371.","journal-title":"Gut"},{"issue":"12","key":"3738_CR46","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1002\/ijc.28310","volume":"133","author":"AP Trotta","year":"2013","unstructured":"Trotta AP, et al. Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K\/Akt signaling and inhibition of prostate cancer cell proliferation. Int J Cancer. 2013;133(12):2812\u201323.","journal-title":"Int J Cancer"},{"key":"3738_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2017.01.031","volume":"653","author":"M Lin","year":"2017","unstructured":"Lin M, Jiang M, Ding F, Cao Z. Syntaxin-4 and SNAP23 act as exocytic SNAREs to release NGF from cultured Schwann cells. Neurosci Lett. 2017;653:97\u2013104.","journal-title":"Neurosci Lett"},{"issue":"7","key":"3738_CR48","doi-asserted-by":"publisher","first-page":"e994","DOI":"10.1002\/ctm2.994","volume":"12","author":"X Pan","year":"2022","unstructured":"Pan X, et al. Circular RNA circ-TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA. Clin Transl Med. 2022;12(7):e994.","journal-title":"Clin Transl Med"},{"issue":"1","key":"3738_CR49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00432-012-1307-y","volume":"139","author":"K Usukura","year":"2013","unstructured":"Usukura K, et al. Tripeptidyl peptidase II in human oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2013;139(1):123\u201330.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"3738_CR50","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ymthe.2020.01.021","volume":"28","author":"D Leboeuf","year":"2020","unstructured":"Leboeuf D, et al. Downregulation of the Arg\/N-degron pathway sensitizes cancer cells to chemotherapy in vivo. Mol Ther. 2020;28(4):1092\u2013104.","journal-title":"Mol Ther"},{"key":"3738_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jprot.2017.07.012","volume":"166","author":"E Maffioli","year":"2017","unstructured":"Maffioli E, et al. Proteomic analysis of the secretome of human bone marrow-derived mesenchymal stem cells primed by pro-inflammatory cytokines. J Proteomics. 2017;166:115\u201326.","journal-title":"J Proteomics"},{"issue":"1","key":"3738_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1293\/tox.2013-0043","volume":"27","author":"T Ohira","year":"2014","unstructured":"Ohira T, et al. Systemic histopathology of infant rats exposed to busulfan. J Toxicol Pathol. 2014;27(1):25\u20139.","journal-title":"J Toxicol Pathol"},{"key":"3738_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reprotox.2022.11.002","volume":"115","author":"L Zhao","year":"2023","unstructured":"Zhao L, et al. Mechanisms underlying impaired spermatogenic function in orchitis induced by busulfan. Reprod Toxicol. 2023;115:1\u20137.","journal-title":"Reprod Toxicol"},{"issue":"1","key":"3738_CR54","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12906-022-03650-w","volume":"22","author":"A Rostami","year":"2022","unstructured":"Rostami A, et al. Ellagic acid effects on testis, sex hormones, oxidative stress, and apoptosis in the relative sterility rat model following busulfan administration. BMC Complement Med Ther. 2022;22(1):170.","journal-title":"BMC Complement Med Ther"},{"issue":"11","key":"3738_CR55","doi-asserted-by":"publisher","first-page":"e526","DOI":"10.1016\/S2352-3026(16)30114-4","volume":"3","author":"IH Bartelink","year":"2016","unstructured":"Bartelink IH, et al. Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis. Lancet Haematol. 2016;3(11):e526\u201336.","journal-title":"Lancet Haematol"},{"key":"3738_CR56","doi-asserted-by":"publisher","first-page":"963689720929683","DOI":"10.1177\/0963689720929683","volume":"29","author":"L Moussa","year":"2020","unstructured":"Moussa L, et al. BMP antagonists secreted by mesenchymal stromal cells improve colonic organoid formation: application for the treatment of radiation-induced injury. Cell Transplant. 2020;29:963689720929683.","journal-title":"Cell Transplant"},{"issue":"1","key":"3738_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13287-021-02275-z","volume":"12","author":"J Lu","year":"2021","unstructured":"Lu J, et al. Human placental mesenchymal stem cells ameliorate chemotherapy-induced damage in the testis by reducing apoptosis\/oxidative stress and promoting autophagy. Stem Cell Res Ther. 2021;12(1):199.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3738_CR58","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13287-020-01803-7","volume":"11","author":"C Qian","year":"2020","unstructured":"Qian C, et al. Human amnion mesenchymal stem cells restore spermatogenesis in mice with busulfan-induced testis toxicity by inhibiting apoptosis and oxidative stress. Stem Cell Res Ther. 2020;11(1):290.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3738_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2015.06.012","volume":"366","author":"NH Nicolay","year":"2015","unstructured":"Nicolay NH, Lopez Perez R, Debus J, Huber PE. Mesenchymal stem cells\u2014A new hope for radiotherapy-induced tissue damage? Cancer Lett. 2015;366(2):133\u201340.","journal-title":"Cancer Lett"},{"issue":"6","key":"3738_CR60","doi-asserted-by":"publisher","first-page":"e1001393","DOI":"10.1371\/journal.pgen.1001393","volume":"7","author":"A Ghazalpour","year":"2011","unstructured":"Ghazalpour A, et al. Comparative analysis of proteome and transcriptome variation in mouse. PLoS Genet. 2011;7(6):e1001393.","journal-title":"PLoS Genet"},{"issue":"6","key":"3738_CR61","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21(6):341\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3738_CR62","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211754","author":"P Debnath","year":"2022","unstructured":"Debnath P, Huirem RS, Dutta P, Palchaudhuri S. Epithelial-mesenchymal transition and its transcription factors. 2022. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20211754."},{"issue":"50","key":"3738_CR63","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.1038\/s41388-021-02058-z","volume":"40","author":"R Liu","year":"2021","unstructured":"Liu R, et al. O-GlcNAc modified-TIP60\/KAT5 is required for PCK1 deficiency-induced HCC metastasis. Oncogene. 2021;40(50):6707\u201319.","journal-title":"Oncogene"},{"issue":"2","key":"3738_CR64","first-page":"207","volume":"38","author":"H Tian","year":"2017","unstructured":"Tian H, et al. Downregulation of AZGP1 by Ikaros and histone deacetylase promotes tumor progression through the PTEN\/Akt and CD44s pathways in hepatocellular carcinoma. Carcinogenesis. 2017;38(2):207\u201317.","journal-title":"Carcinogenesis"},{"issue":"23","key":"3738_CR65","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1007\/s00018-021-03961-0","volume":"78","author":"CAE Westrip","year":"2021","unstructured":"Westrip CAE, et al. Developmentally regulated GTPases: structure, function and roles in disease. Cell Mol Life Sci. 2021;78(23):7219\u201335.","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"3738_CR66","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1007\/s10620-020-06812-3","volume":"66","author":"L Lu","year":"2021","unstructured":"Lu L, et al. DRG1 maintains intestinal epithelial cell junctions and barrier function by regulating RAC1 activity in necrotizing enterocolitis. Dig Dis Sci. 2021;66(12):4237\u201350.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"3738_CR67","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ymthe.2006.05.016","volume":"14","author":"N Noiseux","year":"2006","unstructured":"Noiseux N, et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther. 2006;14(6):840\u201350.","journal-title":"Mol Ther"},{"issue":"3","key":"3738_CR68","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bbrc.2007.01.045","volume":"354","author":"Y Iso","year":"2007","unstructured":"Iso Y, et al. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun. 2007;354(3):700\u20136.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03738-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-03738-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03738-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T21:05:00Z","timestamp":1714338300000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-03738-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3738"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-03738-9","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3413904\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"assertion":[{"value":"6 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Organoids used in this study had previously been generated from biopsies obtained from individuals initially suspected of coeliac disease, but declared free of pathology, within the institutional review board study protocol METC 10-402\/K approved first on 6 June 2011 and thereafter renewed approval on 5 December 2019. All samples had been obtained after written informed consent, were biobanked, and the current use falls under their permission. MSCs were isolated from third-party non-HLA-matched healthy bone marrow donors as approved by the Dutch Central Committee on Research Involving Human Subjects (CCMO, Biobanking bone marrow for MSC expansion, NL41015.041.12; approved on 17 January 2013) and all samples were obtained with written informed consent from the bone marrow donor or parent\/legal guardian of the donor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the publication for this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}